Dela Cerna, Dionesio C.
HRN: 25-30-28 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/18/2024
06/25/2024
IV
2.25g
Q6H
Sepsis Sec To DM Foot, Right
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Bone & JointSkin & Soft TissueDisseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes